SCHEMBL23830479

SCHEMBL23830479

CC(C)CC(=O)Nc1nc(Cl)ncc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
TSHR P16473 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
PTPN1 P18031 2/20 0.41
HPGD P15428 5/20 0.40
RAB9A P51151 2/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.40
THRB P10828 1/20 0.40
MAPT P10636 2/20 0.39
ADORA1 P30542 1/20 0.38
GAA P10253 1/20 0.38
TP53 P04637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23830967 0.81 SMN1; SMN2 (0.49) KDM4ETSHRL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL23830455 0.74 KMT2A (0.53) KDM4EL3MBTL1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL23050262 0.74 L3MBTL1 (0.39) L3MBTL1ALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL23050297 0.74 L3MBTL1 (0.39) L3MBTL1ALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL18634006 0.74 ALDH1A1 (0.43) L3MBTL1ALDH1A1SMN1; SMN2HPGDKMT2A
SCHEMBL14485389 0.73 L3MBTL1 (0.50) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMAPK1
SCHEMBL16784839 0.72 ALDH1A1 (0.40) L3MBTL1ALDH1A1HPGDKMT2A
SCHEMBL31521352 0.72 ALDH1A1 (0.48) L3MBTL1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL31521348 0.72 ALDH1A1 (0.48) L3MBTL1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL3565874 0.72 KMT2A (0.53) KDM4EL3MBTL1ALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883925-A1 CYCLIC UREAS Sironax Ltd (KY) 2021-09-29 EP disclosed
US-20210292305-A1 Cyclic Ureas SIRONAX LTD (KY) 2021-09-23 US disclosed
US-20210292305-A1 Cyclic Ureas SIRONAX LTD (KY) 2021-09-23 US disclosed
CN-113302183-A Cyclic ureas 圣瑞诺有限公司 2021-08-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292305-A1 Cyclic Ureas RIPK1, RIPK3, RIPK4 KDM4E 3602/4885TSHR 1632/4885L3MBTL1 3909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.